Eurofins BioPharma Services Newsletter 39 - December 2024
Eurofins presenta la nuova edizione della newsletter BioPharma NEWS.
Articoli contenuti:
- Eurofins BPT Italy offers single cell analysis for process and product characterisation
- Eurofins PHAST GmbH helps clients detect and control impurities in pharmaceutical drugs earlier
- With USP’s guidelines emphasising quality standards of mRNA analytical methods for characterisation and release testing, Eurofins BPT delivers solutions
- Do your products meet critical attributes for the entire shelf life?
- Eurofins Pharma Bioanalytics Services’ new qPCR delivers fast, accurate, regulatory compliant results
- Eurofins CDMO Alphora expands its service footprint for monoclonal antibodies, therapeutic proteins, and antibody drug conjugate manufacturing
- Eurofins Central Laboratory announces the finalisation of its acquisition of assets for Clinical Trial Pathology Services from DCL Pathology LLC
Download the PDF version of pharma newsletter N°39
Scarica l'edizione precedente della nostra newsletter.
Cordiali saluti
Il comitato editoriale del gruppo Eurofins.